GlassScriptPhysician profile
Lisa K Le
NPI 1770581381
$2,731.44
in general payments reported to CMS, 2019-2025
40 companies · $637 in 2025
The $637 reported for 2025 was more than what 96% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $188 · 2020: $150 · 2021: $319 · 2022: $347 · 2023: $450 · 2024: $641 · 2025: $637.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,728.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,727.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $320.02 | 2019-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Corium, LLC | $300.22 | 2022-2025 | Azstarys |
| Takeda Pharmaceuticals U.S.A., INC. | $218.12 | 2019-2025 | Trintellix |
| Supernus Pharmaceuticals, INC. | $166.25 | 2021-2025 | Qelbree, Qelbree |
| Tris Pharma INC | $152.62 | 2023-2025 | Dyanavel Xr |
| Ironshore Pharmaceuticals INC. | $139.03 | 2019-2024 | Jornay Pm |
| Collegium Pharmaceutical, INC. | $129.47 | 2025 | Jornay Pm |
| Abbott Laboratories | $119.12 | 2023-2025 | Freestyle Libre 3 |
| Novo Nordisk INC | $107.89 | 2020-2023 | Rybelsus |
| Pfizer INC. | $99.81 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $99.36 | 2019-2022 | |
| Sanofi Pasteur INC. | $92.94 | 2023-2025 | |
| Amarin Pharma, INC. | $73.83 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $70.57 | 2019-2022 | |
| Sobi, INC | $61.84 | 2020-2023 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Le listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.